Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) GF Score : 86/100 (As of Apr. 26, 2025)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co GF Score?

Jiangsu Hengrui Pharmaceuticals Co has the GF Score of 86, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 10/10
2. Profitability Rank : 8/10
3. Growth Rank : 8/10
4. GF Value Rank : 9/10
5. Momentum Rank : 4/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Jiangsu Hengrui Pharmaceuticals Co might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Jiangsu Hengrui Pharmaceuticals Co's GF Score

For the Drug Manufacturers - General subindustry, Jiangsu Hengrui Pharmaceuticals Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Hengrui Pharmaceuticals Co's GF Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's GF Score distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's GF Score falls into.

Save Embed

;

Save Embed

;

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Jiangsu Hengrui Pharmaceuticals Co GF Score Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Executives

Zhang Lian Shan	Directors, senior managers
Sun Xu Gen	senior management
Yuan Kai Hong	senior management
Zou Jian Jun	senior management
	senior management
Zhang Yue Hong	senior management
Liu Xiao Han	senior management
Zhou Yun Shu	Directors, senior managers
Liao Cheng	senior management
Wang Hong Sen	senior management
Zhou Song	senior management
Tao Wei Kang	senior management
Jiang Su Mei	senior management
Dai Hong Bin	Directors, senior managers
Sun Jie Ping	Directors, senior managers

Jiangsu Hengrui Pharmaceuticals Co Headlines

No Headlines